Norges Bank’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$72M Buy
+981,577
New +$72M 0.01% 816
2025
Q1
Sell
-834,591
Closed -$42.1M 384
2024
Q4
$42.1M Buy
+834,591
New +$42.1M 0.01% 1027
2024
Q3
Sell
-822,123
Closed -$26.7M 391
2024
Q2
$26.7M Hold
822,123
﹤0.01% 1139
2024
Q1
$20.7M Buy
822,123
+64,633
+9% +$1.63M ﹤0.01% 1254
2023
Q4
$24.6M Sell
757,490
-95,490
-11% -$3.1M ﹤0.01% 1210
2023
Q3
$23.2M Buy
852,980
+120,000
+16% +$3.27M ﹤0.01% 1170
2023
Q2
$16.3M Buy
732,980
+43,948
+6% +$978K ﹤0.01% 1343
2023
Q1
$14.9M Sell
689,032
-81,416
-11% -$1.76M ﹤0.01% 1411
2022
Q4
$15.6M Buy
770,448
+57,221
+8% +$1.16M ﹤0.01% 1385
2022
Q3
$18.3M Buy
713,227
+19,402
+3% +$497K ﹤0.01% 1244
2022
Q2
$16.5M Sell
693,825
-86,897
-11% -$2.07M ﹤0.01% 1329
2022
Q1
$17.6M Sell
780,722
-42,880
-5% -$966K ﹤0.01% 1464
2021
Q4
$16.3M Sell
823,602
-262,800
-24% -$5.2M ﹤0.01% 1571
2021
Q3
$21.4M Buy
1,086,402
+127,727
+13% +$2.51M ﹤0.01% 1443
2021
Q2
$21.1M Buy
958,675
+36,421
+4% +$801K ﹤0.01% 1505
2021
Q1
$21.9M Sell
922,254
-282,244
-23% -$6.71M 0.01% 1493
2020
Q4
$31.5M Sell
1,204,498
-163,214
-12% -$4.27M 0.01% 1283
2020
Q3
$23.8M Sell
1,367,712
-57,684
-4% -$1M 0.01% 1296
2020
Q2
$24M Buy
1,425,396
+369,889
+35% +$6.22M 0.01% 1325
2020
Q1
$12.6M Hold
1,055,507
﹤0.01% 1507
2019
Q4
$12.8M Hold
1,055,507
﹤0.01% 1728
2019
Q3
$14.9M Buy
1,055,507
+182,649
+21% +$2.58M ﹤0.01% 1623
2019
Q2
$9.73M Buy
872,858
+167,533
+24% +$1.87M ﹤0.01% 1807
2019
Q1
$8.28M Hold
705,325
﹤0.01% 1856
2018
Q4
$9.42M Hold
705,325
﹤0.01% 1767
2018
Q3
$9.89M Buy
705,325
+89,300
+14% +$1.25M ﹤0.01% 1821
2018
Q2
$9.68M Buy
616,025
+140,264
+29% +$2.2M ﹤0.01% 1812
2018
Q1
$7.83M Buy
+475,761
New +$7.83M ﹤0.01% 1813